logo

AKTX

Akari Therapeutics·NASDAQ
--
--(--)
--
--(--)

AKTX fundamentals

Akari Therapeutics (AKTX) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.08 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.08
--
Report date
Aug 13, 2025
Earnings Call
11:00 AM on Aug 18, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Akari Therapeutics (AKTX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Akari Therapeutics (AKTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Akari Therapeutics (AKTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Akari Therapeutics (AKTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Akari Therapeutics (AKTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Akari Therapeutics (AKTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield